Medical Ultrasound Instrument Global Market Report 2025

The medical ultrasound instrument market size is expected to see strong growth in the next few years. It will grow to $13.7 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The projected growth in the forecast period can be attributed to the increasing demand for telemedicine and remote diagnostics, the growing use of ultrasound in cancer diagnostics, a rise in the prevalence of cardiovascular diseases, a rising preference for safe imaging techniques, and an increasing demand for minimalist healthcare solutions. Key trends expected during this period include integration with electronic health records, collaboration with robotics for enhanced precision, innovations in contrast-enhanced ultrasound, advancements in high-resolution imaging, and integration with wearable health devices.

The growing prevalence of chronic diseases is expected to drive the expansion of the medical ultrasound instrument market in the near future. Chronic diseases are long-term health conditions that typically develop slowly and require continuous management. These include diabetes, heart disease, hypertension, arthritis, chronic respiratory diseases, cancer, and obesity. The rise in chronic diseases is primarily attributed to lifestyle factors such as poor diet, lack of physical activity, and other health-related complications. Medical ultrasound instruments play a crucial role in managing these diseases by providing non-invasive, real-time imaging, making them ideal for ongoing monitoring and diagnosis. These instruments help reduce the need for exploratory procedures, providing quick and accurate assessments that enhance patient care and treatment efficiency. For example, in June 2024, the National Health Service (NHS) in the UK reported an 18% increase in pre-diabetes cases in England, rising by 549,000 from 3,065,825 in 2022 to 3,615,330 in 2023. As a result, the growing prevalence of chronic diseases is significantly contributing to the growth of the medical ultrasound instrument market.

Leading companies in the medical ultrasound instrument market are focusing on developing innovative products, such as wireless handheld ultrasound devices, to improve portability, increase accessibility, and reduce costs for point-of-care diagnostics. A wireless handheld ultrasound device is a compact, portable system that connects to smartphones or tablets through wireless technology, enabling real-time imaging and diagnostics without the need for bulky equipment or traditional power sources. For example, in August 2023, GE Healthcare Technologies Inc., a US-based medical technology company, introduced the Vscan Air SL, a wireless handheld ultrasound device designed for rapid cardiac and vascular assessments. This device features a dual-headed probe with both sector and linear transducers, allowing for fast and high-quality assessments at the point of care. Its compact, portable design and advanced imaging technologies provide clinicians with high-resolution images and enable seamless switching between different types of examinations both inside and outside the hospital.

In May 2023, Probo Medical LLC, a UK-based diagnostic imaging equipment company, acquired National Ultrasound Inc. for an undisclosed amount. This acquisition is part of Probo Medical's strategy to enhance and expand its ultrasound sales, service, and repair capabilities, particularly in the veterinary market. It also aims to accelerate growth and strengthen its position as a leading provider of medical imaging equipment and services. National Ultrasound Inc., based in the US, specializes in providing medical ultrasound instruments.

Major players in the medical ultrasound instrument market are Hitachi Ltd., Canon Inc., Siemens Healthineers AG, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., GE Healthcare, Konica Minolta Inc., Hologic Inc., SonoScape Medical Corp., Samsung Medison Co Ltd, Edan Instruments Inc., Chison Medical Imaging Co Ltd., Shenzhen Landwind Industry Co Ltd., United Imaging Healthcare Co. Ltd., Biocare Medical, Teratech Corporation, Excelsior Union Ltd., Alpinion Medical Systems, Dawei Medical Co Ltd., Draminski S.A.

North America was the largest region in the medical ultrasound instrument market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in medical ultrasound instrument report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the medical ultrasound instrument market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical ultrasound instrument market consists of sales of portable ultrasound devices, ultrasound accessories, ultrasound probes, and doppler ultrasound systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Medical ultrasound instruments are diagnostic tools that utilize high-frequency sound waves to generate real-time images of the body's internal structures, such as organs, tissues, and blood vessels. These devices are used for non-invasive examinations of internal organs, tissues, and fetal development. They are commonly employed for diagnostic purposes, such as monitoring pregnancy, assessing heart function, and guiding specific medical procedures.

The primary types of medical ultrasound instruments include diagnostic ultrasound equipment, therapeutic ultrasound equipment, ultrasound software, and accessories and consumables. Diagnostic ultrasound equipment refers to medical imaging devices that use high-frequency sound waves to produce real-time images of internal body structures for diagnostic purposes. Key technologies in this category include 2D, 3D, and 4D ultrasound, as well as Doppler ultrasound. These devices come in various formats based on portability, such as portable ultrasound systems, handheld ultrasound devices, and cart-based ultrasound units. They are used in a wide range of clinical applications, including radiology, cardiology, obstetrics and gynecology, vascular imaging, urology, orthopedics, and other medical fields. The end users of ultrasound instruments include hospitals, diagnostic centers, ambulatory surgical centers, and other healthcare facilities.

The medical ultrasound instrument market research report is one of a series of new reports that provides medical ultrasound instrument market statistics, including the medical ultrasound instrument industry's global market size, regional shares, competitors with the medical ultrasound instrument market share, detailed medical ultrasound instrument market segments, market trends and opportunities, and any further data you may need to thrive in the medical ultrasound instrument market. This medical ultrasound instrument market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The medical ultrasound instrument market size has grown strongly in recent years. It will grow from $9.05 billion in 2024 to $9.84 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth during the historic period can be attributed to the rising demand for non-invasive diagnostic techniques, the increasing prevalence of chronic diseases, a growing aging population, greater awareness of early disease detection, and a rising preference for safe and non-invasive diagnostic methods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.